Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Continuous Renal Replacement Therapy
100%
Older Adults
73%
Kidney Disease
71%
Renal Replacement
70%
Acute Kidney Injury
68%
Chronic Kidney Disease
26%
Pediatric Acute Kidney Injury
26%
Therapy Initiation
25%
Human Erythrocytes
24%
Iloprost
18%
Renal Replacement Therapy
17%
Major Adverse Kidney Events
16%
Receptor-mediated
15%
Disease Registry
15%
Sepsis
15%
Erythrocytes
15%
Fluid Overload
14%
Intensive Care Unit Mortality
14%
Injury Management
13%
Clinical Data
13%
Injury Outcomes
13%
Adenosine Triphosphate Production
13%
Administrative Data
13%
Isoproterenol
13%
Prostaglandin Analogs
13%
Phosphodiesterase
13%
Late Development
13%
Injury Rate
13%
Cyclic Adenosine Monophosphate (cAMP)
13%
Management Challenges
13%
Acute Kidney Injury Biomarkers
13%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
13%
Cystatin C (Cys C)
13%
Biomedical Informatics
13%
ICU Mortality
13%
Machine Learning Prediction
13%
Prediction Model
13%
Comparative Analysis
13%
Critically Ill children
13%
Hyperglycemia
13%
Kidney Outcomes
13%
Thrombocytopenia
13%
Functional Scale
13%
Functional Outcome
13%
Pediatric Patients
13%
Infant Dialysis
13%
Neonatal Dialysis
13%
Odds Ratio
12%
IP Receptor
10%
Serum Creatinine
10%
Medicine and Dentistry
Acute Kidney Injury
79%
Renal Replacement
70%
Continuous Renal Replacement Therapy
62%
Nephropathy
58%
Continuous Kidney Replacement Therapy
46%
Pediatrics
37%
Intensive Care Unit
26%
Renal Replacement Therapy
19%
Biological Marker
16%
Sepsis
15%
Chronic Kidney Disease
14%
Hypervolemia
13%
Prevalence
13%
Kidney Disorder
13%
Thrombocytopenia
13%
Hyperglycemia
13%
Functional Status
13%
Pediatrics Patient
13%
Pediatric Nephrology
13%
Neonate
13%
Odds Ratio
11%
Neonatal Intensive Care Unit
7%
Cohort Effect
6%
Platelet
6%
Extracorporeal Membrane Oxygenation
6%
Creatinine
5%
Fluid Balance
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Comorbidity
5%